Results 141 to 150 of about 5,207 (190)
Some of the next articles are maybe not open access.
Journal of Gastroenterology, 2002
Barrett's esophagus is an acquired condition resulting from severe esophageal mucosal injury. It still remains unclear why some patients with gastroesophageal reflux disease develop Barrett's esophagus whereas others do not. The diagnosis of Barrett's esophagus is established if the squamocolumnar junction is displaced proximal to the gastroesophageal ...
Akira, Terano +5 more
openaire +5 more sources
Barrett's esophagus is an acquired condition resulting from severe esophageal mucosal injury. It still remains unclear why some patients with gastroesophageal reflux disease develop Barrett's esophagus whereas others do not. The diagnosis of Barrett's esophagus is established if the squamocolumnar junction is displaced proximal to the gastroesophageal ...
Akira, Terano +5 more
openaire +5 more sources
Current Treatment Options in Gastroenterology, 2014
Barrett's esophagus (BE) is the most important and recognizable precursor lesion for esophageal adenocarcinoma (EAC), which is the one of the fastest-growing cancers in the Western world (600 % in the U.S. in the last 40 years), and therefore it is critical to manage the risk of cancer present in BE.
Shanmugarajah, Rajendra, Prateek, Sharma
openaire +2 more sources
Barrett's esophagus (BE) is the most important and recognizable precursor lesion for esophageal adenocarcinoma (EAC), which is the one of the fastest-growing cancers in the Western world (600 % in the U.S. in the last 40 years), and therefore it is critical to manage the risk of cancer present in BE.
Shanmugarajah, Rajendra, Prateek, Sharma
openaire +2 more sources
Current Opinion in Gastroenterology, 2004
Strides have been made in the past year to identify means of decreasing mortality from esophageal adenocarcinoma. This requires a thorough understanding of the risk factor for its development, Barrett esophagus. This article summarizes the most up-to-date and important advancements involving the epidemiology, screening, pathogenesis, surveillance, and ...
John A, Bonino, Prateek, Sharma
openaire +2 more sources
Strides have been made in the past year to identify means of decreasing mortality from esophageal adenocarcinoma. This requires a thorough understanding of the risk factor for its development, Barrett esophagus. This article summarizes the most up-to-date and important advancements involving the epidemiology, screening, pathogenesis, surveillance, and ...
John A, Bonino, Prateek, Sharma
openaire +2 more sources
Current Opinion in Gastroenterology, 1988
Intestinal metaplasia in Barrett's esophagus is a major risk factor for esophageal adenocarcinoma, a tumor whose incidence rate has more than tripled in the United States over the past 2 decades. Studies have identified a number of molecular abnormalities that may be involved in the progression from dysplasia to cancer in Barrett's esophagus, including
openaire +5 more sources
Intestinal metaplasia in Barrett's esophagus is a major risk factor for esophageal adenocarcinoma, a tumor whose incidence rate has more than tripled in the United States over the past 2 decades. Studies have identified a number of molecular abnormalities that may be involved in the progression from dysplasia to cancer in Barrett's esophagus, including
openaire +5 more sources
Archives of Surgery, 1977
Barrett esophagus is the term describing the presence of an abnormal columnar epithelium in a portion of the esophagus. We have treated 19 patients within the past three years, representing almost 20% of all our esophageal experience; This one pathologic entity has presented as several different clinical pictures: benign stricture, peptic ulceration of
L R, Radigan +3 more
openaire +2 more sources
Barrett esophagus is the term describing the presence of an abnormal columnar epithelium in a portion of the esophagus. We have treated 19 patients within the past three years, representing almost 20% of all our esophageal experience; This one pathologic entity has presented as several different clinical pictures: benign stricture, peptic ulceration of
L R, Radigan +3 more
openaire +2 more sources
Journal of Gastroenterology and Hepatology, 2011
AbstractBarrett's esophagus is an acquired metaplastic abnormality in which the normal stratified squamous epithelium lining of the esophagus is replaced by an intestinal‐like columnar epithelium. While in itself a benign and asymptomatic disorder, the clinical importance of this relatively common condition relates to its role as a precursor lesion to ...
Phillips, Wayne A. +4 more
openaire +4 more sources
AbstractBarrett's esophagus is an acquired metaplastic abnormality in which the normal stratified squamous epithelium lining of the esophagus is replaced by an intestinal‐like columnar epithelium. While in itself a benign and asymptomatic disorder, the clinical importance of this relatively common condition relates to its role as a precursor lesion to ...
Phillips, Wayne A. +4 more
openaire +4 more sources
Current Opinion in Internal Medicine, 2003
The importance of an in-depth understanding about Barrett esophagus is ultimately to decrease the mortality and morbidity from esophageal adenocarcinoma cancer by early detection of metaplasia and dysplasia and appropriate therapy. This review summarizes several publications in the past year related to the epidemiology, pathogenesis, screening and ...
Sanjeev, Slehria, Prateek, Sharma
openaire +2 more sources
The importance of an in-depth understanding about Barrett esophagus is ultimately to decrease the mortality and morbidity from esophageal adenocarcinoma cancer by early detection of metaplasia and dysplasia and appropriate therapy. This review summarizes several publications in the past year related to the epidemiology, pathogenesis, screening and ...
Sanjeev, Slehria, Prateek, Sharma
openaire +2 more sources
Chest Surgery Clinics of North America, 1994
The development of the columnar-lined lower esophagus, or Barrett's disease, is an acquired condition due to reflux of gastric and duodenal contents. The medical treatment of patients with reflux disease and Barrett's esophagus is currently the same as for patients with reflux without Barrett's disease which may indicate more aggressive antireflux ...
M, Pera, V F, Trastek
openaire +2 more sources
The development of the columnar-lined lower esophagus, or Barrett's disease, is an acquired condition due to reflux of gastric and duodenal contents. The medical treatment of patients with reflux disease and Barrett's esophagus is currently the same as for patients with reflux without Barrett's disease which may indicate more aggressive antireflux ...
M, Pera, V F, Trastek
openaire +2 more sources
JAMA, 2022
ImportanceBarrett esophagus is characterized by the replacement of normal esophageal squamous cell epithelium with columnar metaplasia and affects approximately 5% of people in the US and approximately 1% worldwide. Approximately 3% to 5% of patients with Barrett esophagus will be diagnosed with esophageal adenocarcinoma in their lifetime ...
openaire +2 more sources
ImportanceBarrett esophagus is characterized by the replacement of normal esophageal squamous cell epithelium with columnar metaplasia and affects approximately 5% of people in the US and approximately 1% worldwide. Approximately 3% to 5% of patients with Barrett esophagus will be diagnosed with esophageal adenocarcinoma in their lifetime ...
openaire +2 more sources
Barrett’s esophagus and Barrett’s carcinoma
Current Oncology Reports, 2003The alarming rise in the incidence of esophageal adenocarcinomas in the Western world has focused interest on so-called Barrett's esophagus. Barrett's esophagus is characterized by specialized intestinal epithelium replacing the normal squamous epithelium in the distal esophagus and is considered a consequence of long-lasting and severe ...
Burkhard H A, von Rahden +2 more
openaire +2 more sources